CRMD - Citius: Halt For Superiority On The Horizon June, 15 2021 10:41 AM CorMedix Inc. IDMC meets on June 29 for Superiority review. Mino-Lok has no competition. Price target increased to $10. Mino-Lok has Fast Track designation. Enough cash through commercialization. For further details see: Citius: Halt For Superiority On The Horizon